Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler–Weber syndrome, is a rare genetic disease, which is characterized by mutations in the endoglin (HHT-1) or ALK-1 (HHT-2) [51] genes. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.